|
English
|
正體中文
|
简体中文
|
總筆數 :2856565
|
|
造訪人次 :
53414328
線上人數 :
808
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 385176-385185 / 2348973 (共234898頁)
<< < 38513 38514 38515 38516 38517 38518 38519 38520 38521 38522 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2009 |
Empirical Models to Predict Parsimoniously the Mass and Number Concentrations of Ultrafine Particulate in Ambient Atmosphere
|
Chio, Chia-Pin; Cheng, Man-Ting; Lin, Yu-Chi; Liao, Chung-Min |
| 臺大學術典藏 |
2018-09-10T07:24:29Z |
Empirical models to predict parsimoniously the mass and number concentrations of ultrafine particulate in ambient atmosphere
|
Chio, C.-P.;Cheng, M.-T.;Lin, Y.-C.;Liao, C.-M.; Chio, C.-P.; Cheng, M.-T.; Lin, Y.-C.; Liao, C.-M.; Chio, Chia-Pin; CHIA-PIN CHIO; Cheng, Man-Ting; Lin, Yu-Chi; Liao, Chung-Min |
| 義守大學 |
2011-05 |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial
|
Jyh-Ming Liou;Chieh-Chang Chen;Mei-Jyh Chen;Chi-Yang Chang;Yu-Jen Fang;Ji-Yuh Lee;Wang-Huei Sheng;Hsiu-Po Wang;Ming-Shiang Wu;Jaw-Town Lin |
| 臺大學術典藏 |
2018-09-10T08:30:14Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou, J.-M. and Chen, C.-C. and Chen, M.-J. and Chang, C.-Y. and Fang, Y.-J. and Lee, J.-Y. and Sheng, W.-H. and Wang, H.-P. and Wu, M.-S. and Lin, J.-T.; JYH-MING LIOU; WANG-HUEI SHENG; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:52Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2021-01-15T03:47:01Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Sheng W.-H.; HSIU-PO WANG; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-26T02:00:03Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; WANG-HUEI SHENG; Wang H.-P.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-05-27T08:21:00Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
JYH-MING LIOU; Chen C.-C.; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-14T06:28:55Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; YU-JEN FANG; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:44Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; MING-SHIANG WU; Lin J.-T. |
顯示項目 385176-385185 / 2348973 (共234898頁)
<< < 38513 38514 38515 38516 38517 38518 38519 38520 38521 38522 > >>
每頁顯示[10|25|50]項目
|
